Algorithm can accurately identify COVID-19 cases, as well as distinguish them from influenza — ScienceDaily

A University of Central Florida researcher is part of a new study showing that artificial intelligence can be nearly as accurate as a physician in diagnosing COVID-19 in the lungs.

The study, recently published in Nature Communications, shows the new technique can also overcome some of the challenges of current testing.

Researchers demonstrated that an AI algorithm could be trained to classify COVID-19 pneumonia in computed tomography (CT) scans with up to 90 percent accuracy, as well as correctly identify positive cases 84 percent of the time and negative cases 93 percent of the time.

CT scans offer a deeper insight into COVID-19 diagnosis and progression as compared to the often-used reverse transcription-polymerase chain reaction, or RT-PCR, tests. These tests have high false negative rates, delays in processing and other challenges.

Another benefit to CT scans is that they can detect COVID-19 in people without symptoms, in those who have

Read More
Read More

Influenza Diagnostics Market Size and Share 2020 Trends, Future Demands, Growth Factors, Emerging Technologies, Global Industry Forecast to 2023

The MarketWatch News Department was not involved in the creation of this content.

Sep 25, 2020 (The Expresswire) —
“Influenza Diagnostics Market”research provides actionable intelligence on major parameters impacting the market, analyses the market performance of key companies, market dynamics of key segments, outlines the market performance across global regions. The insights of the industry over the past 5 years and a forecast until 2023 is provided.

Influenza diagnostic kits are available in both rapid and conventional testing models. These kits can detect influenza virus strains in swab samples collected from the nasal, nasopharyngeal, or oropharyngeal region. Our influenza diagnostics market analysis considers sales from point-of-care testing, immunodiagnostics, and molecular diagnostics kits segments to end-user sectors such as hospitals and diagnostic laboratories, academic and research institutions, and home care. Our analysis also considers the sales of influenza diagnostics in Asia, Europe, North America, and ROW. In 2018, the point-of-care testing

Read More
Read More

Influenza Drugs Market 2020 Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global Forecast To 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 24, 2020 (The Expresswire) —
Global “”Influenza Drugs Market“”(2020-2026) status and position of worldwide and key regions, with perspectives of manufacturers, regions, product types and end industries; this report analyses the topmost companies in worldwide and main regions, and splits the Influenza Drugs market by product type and applications/end industries.The Influenza Drugs market trend research process includes the analysis of different factors affecting the industry, with the government policy, competitive landscape, historical data, market environment, present trends in the market, upcoming technologies,technological innovation, and the technical progress in related industry, and market risks, market barriers,opportunities, and challenges.

Get a sample PDF of the report at-https://www.360researchreports.com/enquiry/request-sample/16172948

The global Influenza Drugs market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026. In 2020, the market was growing at

Read More
Read More